Case Report: Rare Peripheral Neuropathy With Abdominal Wall Allodynia in Extensive-Stage Small-Cell Lung Cancer Treated Using Durvalumab [0.03%]
病例报告：使用度伐利尤单抗治疗广泛期小细胞肺癌伴发罕见外周神经病和腹壁触痛病例
Ruidan Li,Zhen Li,Xiaoqian Zhai et al.
Ruidan Li et al.
Immune checkpoint inhibitors (ICIs), such as PD-1/PD-L1 inhibitors, have revolutionized the treatment of extensive-stage small-cell lung cancer (ES-SCLC). Chemotherapy combined with PD-1 or PD-L1 inhibitors has become the standard first-lin...
Case Reports
Thoracic cancer. 2026 Jul;17(14):e70368. DOI:10.1111/1759-7714.70368 2026
Sequential EGFR T790M, MET c.3010C>G-Associated Exon 14 Alteration, and RET-CCDC6 Fusion in EGFR-Mutant NSCLC: A Case Report [0.03%]
EGFR-T790M、MET c.3010C>G-XI型跳跃突变以及RET-CCDC6融合基因在携带EGFR敏感突变的非小细胞肺癌中的演变：一例报告
Yan Zhu,Chan Wang,Nan-Lin Hu et al.
Yan Zhu et al.
Acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR-mutant non-small-cell lung cancer (NSCLC) is heterogeneous, and serial re-biopsy may uncover actionable mechanisms. We report a 55-year...
Case Reports
Thoracic cancer. 2026 Jul;17(14):e70322. DOI:10.1111/1759-7714.70322 2026
Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two-Center Retrospective Study [0.03%]
常规预治疗CT扫描上肿瘤坏死作为晚期NSCLC免疫检查点抑制剂单药治疗潜在的预后标志物：一项回顾性两中心研究
Eiji Takeuchi,Hirokazu Ogino,Kensuke Kondo et al.
Eiji Takeuchi et al.
Background: The prognostic value of CT-detected tumor necrosis in advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor (ICI) monotherapy remains unclear. This two-center retrospective study...
Multicenter Study
Thoracic cancer. 2026 Jul;17(14):e70363. DOI:10.1111/1759-7714.70363 2026
Development and Internal Validation of a Patient-Level Diagnostic Model Integrating Folate Receptor-Positive Circulating Tumor Cells and Peripheral CD8 Count for Malignant-Versus-Benign Pathology Discrimination in a Pathology-Enriched Pulmonary Nodule Cohort [0.03%]
在病理科富集的肺结节队列中用于恶性与良性病理鉴别的基于患者水平的诊断模型的开发和内部验证：整合叶酸受体阳性循环肿瘤细胞和外周CD8计数
Chunyan Zhang,Xiaoke Sun,Hongjian Su et al.
Chunyan Zhang et al.
Background: In pathology-enriched referred hospital cohorts, stable radiologic-pathologic linkage is often unavailable, so patient-level malignant pathology may be a more reliable endpoint than lesion-specific malignancy....
Perioperative Aspirin Continuation in Patients Requiring Secondary Prevention Undergoing Anatomical Lung Resection: A Propensity Score-Weighted Analysis [0.03%]
接受解剖学肺切除术需要二级预防患者的围手术期阿司匹林延续：倾向性评分加权分析
Junichi Murakami,Sota Yoshimine,Mototsugu Shimokawa et al.
Junichi Murakami et al.
Background: Managing perioperative aspirin for secondary prevention during lung resection balances major bleeding against catastrophic thromboembolism. Evidence guiding this scenario, especially for real-world strategies ...
Atypical Behavior in a Typical Carcinoid: When Minimal Proliferation Meets Lympho-Vascular Invasion-A Case Report [0.03%]
典型的类癌肿瘤中不典型的生物学行为：当低级别增殖遇上淋巴血管侵犯
Qilian Wang,Xi Chen,Sicheng Zhou et al.
Qilian Wang et al.
Typical carcinoid tumors (TC) are a low-grade neuroendocrine tumor characterized by low proliferation activity and an overall favorable prognosis. Lympho-vascular invasion is uncommon in TC and is more frequently associated with atypical ca...
Case Reports
Thoracic cancer. 2026 Jul;17(14):e70347. DOI:10.1111/1759-7714.70347 2026
Importance of Multimodal Testing for Novel ALK Fusions: A Case of MTHFD1L-ALK Positive Lung Squamous Cell Carcinoma With Negative IHC [0.03%]
新型ALK融合的多模态检测的重要性：一例免疫组化阴性的MTHFD1L-ALK阳性肺鳞癌病例
Huiwen Yang,Shuqiao Zheng,Jiaohui Pang et al.
Huiwen Yang et al.
Anaplastic lymphoma kinase (ALK) rearrangements are rare in lung squamous cell carcinoma (LSCC), with the clinical efficacy of ALK tyrosine kinase inhibitors (TKIs) in patients harboring uncommon ALK fusions remaining poorly characterized. ...
Case Reports
Thoracic cancer. 2026 Jul;17(14):e70348. DOI:10.1111/1759-7714.70348 2026
Association Between Treatment Sequencing and Overall Survival in Stage IV NSCLC With Brain Metastases: A National Cancer Database Study [0.03%]
一项全国癌症数据库研究：IV期伴脑转移的非小细胞肺癌治疗顺序与总生存率之间的关系
Anand Shah,Pranav Gwalani,Merry Zhai et al.
Anand Shah et al.
Background: The optimal sequencing of brain-directed radiation and systemic therapy in stage IV non-small cell lung cancer (NSCLC) with brain metastases remains uncertain in the era of CNS-active systemic agents. We evalu...
Endobronchial Metastasis From Osteosarcoma in an Adolescent: A Rare Case Report [0.03%]
青少年骨肉瘤支气管内转移一例罕见病例报告
Yanling He,Yanping Chen,Yanhong Liu et al.
Yanling He et al.
A 14-year-old female was diagnosed with osteosarcoma of the left proximal tibia and underwent neoadjuvant chemotherapy followed by wide local resection and limb-sparing surgery. Thirteen months after surgery, she developed coughing, wheezin...
Case Reports
Thoracic cancer. 2026 Jul;17(14):e70355. DOI:10.1111/1759-7714.70355 2026